Riccardo Maggiore

Riccardo Maggiore

هل تحتاج الى موعد؟

اتصل بنا وسنعتني بك.
Secure your spot with the doctor
View doctor availability
Send request

السيرة الذاتية

Dr. Riccardo Maggiore is a general and endocrine surgeon, Head of the Endocrine Surgery Functional Unit within the Week Surgery Unit of IRCCS Ospedale San Raffaele, directed by Prof. Riccardo Rosati.

After graduating in Medicine and Surgery from Vita-Salute San Raffaele University of Milan in 2010, he specialized in General Surgery at the same university in 2016.

Clinically, he mainly focuses on the diagnostic and therapeutic management of endocrine diseases requiring surgery (benign or malignant thyroid nodules with or without lymph node involvement, primary or secondary hyperparathyroidism, secreting or non-secreting adrenal nodules).

In this field, he adopts both traditional and minimally invasive surgical approaches, using advanced technologies (e.g., intraoperative monitoring of recurrent laryngeal nerves – IONM – for which he attended specific training courses, and the study of parathyroid vascularization using NIR fluorescence angiography with indocyanine green). He has performed about 2,000 endocrine surgical procedures as First Surgeon and has taken part in over 6,000 endocrine surgeries as a member of the surgical team.

He designs a personalized surgical pathway for each patient after multidisciplinary evaluation involving endocrinologists (including pediatric endocrinologists), radiologists, nuclear medicine physicians, ultrasound specialists in endocrine diseases, bone metabolism specialists, and nephrologists. Special attention is given to defining the surgical pathway and follow-up for thyroid cancer, in accordance with the most recent international guidelines, always in a multidisciplinary setting involving endocrinologists. He is the Organizational Coordinator of the Thyroid Cancer Disease Unit at IRCCS Ospedale San Raffaele.

He regularly participates as a speaker at national and international congresses.

اقرأ المزيدأقرأ أقل

معرض الوسائط المتعددة

المنشورات

أحدث المنشورات

Necessity of therapy for post-thyroidectomy hypocalcaemia: a multi-centre experience
Langenbecks Arch Surg. 2015. DOI 10.1007/s00423-015-1292-0.
De Pasquale L, Sartori PV, Vicentini L, Beretta E, Boniardi M, Leopaldi E, Gini P, La Manna L, Cozzaglio L, Steffano GB, Andreani S, Badiali S, Cantoni GM, Galimberti A, Ghilardi G, Gusmeroli M, Maggiore R, Morenghi E, Pauna J, Poggi L, Testa V.
Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial
Surg Endosc. 2020. DOI 10.1007/s00464-019-06730-0.
De Nardi P, Elmore U, Maggi G, Maggiore R, Boni L, Cassinotti E, Fumagalli U, Gardani M, De Pascale S, Parise P, Vignali A, Rosati R.
miR-126-3p contributes to parathyroid tumor angiogenesis
Endocr Relat Cancer. 2021. DOI 10.1530/ERC-20-0313.
Verdelli C, Forno I, Morotti A, Maggiore R, Mari G, Vicentini L, Ferrero S, Kuhn E, Vaira V, Corbetta S.
Yes-Associated protein 1 is a novel calcium sensing receptor target in human parathyroid tumors
Int J Mol Sci. 2021. DOI 10.3390/ijms22042016.
Tavanti GS, Verdelli C, Morotti A, Maroni P, Guarnieri V, Scillitani A, Silipigni R, Guerneri S, Maggiore R, Mari G, Vicentini L, Dalino Ciaramella P, Vaira V, Corbetta S.
Impact of the 8th edition of the AJCC-TNM staging system on estimated cancer-specific survival in patients aged 45–54 years at diagnosis with differentiated thyroid carcinoma: a single center report
Int J Endocrinol. 2021. DOI 10.1155/2021/8820364.
Maggiore R, Perticone F, Mari G, Pasquali R, Bosi E, Scavini M, Lanzi R, Rosati R.
Malignancy risk in indeterminate thyroid nodules with Hürthle cells: role of autoimmune thyroiditis
Endocrine. 2021. DOI 10.1007/s12020-021-02932-6.
Perticone F, Maggiore R, Mari G, Frara S, Baldassarre P, Doglioni C, Lena MS, Rosati R, Lanzi R, Giustina A.
Focal high-grade areas with a tumor-in-tumor pattern: another feature of pediatric DICER1-associated thyroid carcinoma?
Endocr Pathol. 2025. DOI 10.1007/s12022-025-09863-2.
Schiavo Lena M, Sánchez-Ares M, Brunetto E, Abdulkader-Nallib I, Maggiore R, Barbieri D, Vigone MC, Perticone F, Lanzi R, Presi S, Carrera P, Cangi MG, Arrigoni G, Doglioni C, Cameselle-Teijeiro JM.
Aberrant promoter methylation, expression and function of RASSF1A gene in a series of Italian parathyroid tumors
Endocrine. 2024. DOI 10.1007/s12020-024-04113-7.
Verdelli C, Fabrizio FP, Maroni P, Morotti A, Tavanti GS, Carrara S, Guarnieri V, Cetani F, Scillitani A, Maggiore R, Perticone F, Vaira V, Muscarella LA, Corbetta S.
Osteocalcin modulates parathyroid cell function in human parathyroid tumors
Front Endocrinol. 2023. DOI 10.3389/fendo.2023.1129930.
Verdelli C, Tavanti GS, Forno I, Vaira V, Maggiore R, Vicentini L, Ciaramella PD, Perticone F, Lombardi G, Corbetta S.
Heterogeneous Transcriptional Landscapes in Human Sporadic Parathyroid Gland Tumors
Int J Mol Sci. 2024. DOI 10.3390/ijms251910782.
Verdelli C, Carrara S, Maggiore R, Ciaramella PD, Corbetta S.